Literature DB >> 25482553

Phthalazin-1(2H)-one as a remarkable scaffold in drug discovery.

Noemí Vila1, Pedro Besada1, Tamara Costas1, M Carmen Costas-Lago1, Carmen Terán2.   

Abstract

Phthalazinones are an important kind of nitrogen atom containing heterocyclic compounds due to their synthetic and pharmacological versatility. This fused heterocycle system represents a common structural feature for many bioactive compounds showing a variety of pharmacological activities such as anticancer, anti-diabetic, anti-asthmatic, antihistaminic, antihypertensive, antithrombotic, anti-inflammatory, analgesic, antidepressant or antimicrobial agents, which makes it an attractive scaffold for the design and development of new drugs. This review summarizes detailed and updated information, described in recent non-patent literature, about the most relevant pharmacological properties of phthalazinone derivatives, highlighting the application of this potent pharmacophore in drug discovery.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Azaheterocycle; Bioactive compound; Biological target; Pharmacological activity; Phthalazin-1(2H)-one; Synthesis

Mesh:

Substances:

Year:  2014        PMID: 25482553     DOI: 10.1016/j.ejmech.2014.11.043

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  2 in total

1.  Novel Pyran-Linked Phthalazinone-Pyrazole Hybrids: Synthesis, Cytotoxicity Evaluation, Molecular Modeling, and Descriptor Studies.

Authors:  M Shaheer Malik; Basim H Asghar; Riyaz Syed; Reem I Alsantali; Moataz Morad; Hatem M Altass; Ziad Moussa; Ismail I Althagafi; Rabab S Jassas; Saleh A Ahmed
Journal:  Front Chem       Date:  2021-05-24       Impact factor: 5.221

2.  Amino- and polyaminophthalazin-1(2H)-ones: synthesis, coordination properties, and biological activity.

Authors:  Zbigniew Malinowski; Emilia Fornal; Agata Sumara; Renata Kontek; Karol Bukowski; Beata Pasternak; Dariusz Sroczyński; Joachim Kusz; Magdalena Małecka; Monika Nowak
Journal:  Beilstein J Org Chem       Date:  2021-02-25       Impact factor: 2.883

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.